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Abstract
Glial dysfunction has been implicated in a number of neurodegenerative diseases. In this study we investigated the
consequences of glial and oligodendrocyte ablation on neuronal integrity and survival in Drosophila and adult mice,
respectively. Targeted genetic ablation of glia was achieved in the adult Drosophila nervous system using the GAL80-GAL4
system. In mice, oligodendrocytes were depleted by the injection of diphtheria toxin in MOGi-Cre/iDTR double transgenic
animals. Acute depletion of oligodendrocytes induced axonal injury, but did not cause neuronal cell death in mice. Ablation
of glia in adult flies triggered neuronal apoptosis and resulted in a marked reduction in motor performance and lifespan.
Our study shows that the targeted depletion of glia triggers secondary neurotoxicity and underscores the central
contribution of glia to neuronal homeostasis. The models used in this study provide valuable systems for the investigation
of therapeutic strategies to prevent axonal or neuronal damage.
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Introduction
Allcomplexnervous systemsconsistoftwomain celltypes, neurons
and glia. The increasing complexity of the nervous system during
evolution is accompanied by a steady rise in glial cell number.
Whereas only approximately 10% of the 90 000 cells of the central
nervous system (CNS) of Drosophila melanogaster are of glial origin, glia
account for the majority of the cells of the mammalian brain [1]. In
vertebrates central nervous system there are three major classes of
glial cells: oligodendrocytes, astrocytes and microglia. In both the
invertebrate and the vertebrate nervous system, glia participate in an
intimate anatomical relationship with neurons to provide structural
and metabolic support [2,3,4,5,6,7,8,9,10]. There are numerous
examples of how glia engage in neurotransmitter metabolisms, ion
buffering, axon pathfinding, electrical insulation and nutrient
function. These multiple functional interconnections between glia
and neurons, raise the question whether and how the acute loss of glia
affectneuronalintegrity. In Drosophila,theglial-specifichomeodomain
protein, Repo, is essential for survival of the laminar neurons in the
optic lobe [11]. Moreover, mutations in genes such as drop dead and
swiss cheese, have revealed the importance of glia in the functioning of
the adult Drosophila nervous system [12]. In addition, when glial
function is impaired in the developing nervous system of Drosophila
either by mutations in the gene glial cells missing or by targeted genetic
glial ablation, neuronal death is induced non-autonomously [13]. In
mammalian cell culture, astrocytes are required for long-term
survival of neurons [14]. Furthermore, several oligodendrocyte
mouse mutants result in defects causing axonal degeneration in the
CNS [15,16,17,18,19,20,21,22,23]. Together, these studies unam-
biguouslyshow thatglial dysfunctioncan resultin neurodegeneration.
However, none of these studies have addressed whether the acute
depletion of glia in the mature nervous system affects neuronal
survival. This is a relevant question as loss of glia in the adult nervous
system occurs in a number of neurological diseases. For example, in
multiple sclerosis (MS) it is still a matter of debate whether
neurodegeneration is the result of a direct inflammatory attack
against the axon or rather a consequence of oligodendrocyte
dysfunction and demyelination [24,25,26,27]. Especially the latter
scenario is difficult to address in the experimental autoimmune
encephalomyelitis (EAE) model, the most widely used animal model
of MS. To determine whether selective loss of glia in adult brain can
cause acute neurodegeneration, we used an experimental system of
genetic models that allow the ablation of glia in the adult nervous
system of Drosophila or mice.
Results
Oligodendrocyte ablation in MOGi-Cre/iDTR mice
induces axonal damage
For oligodendrocyte ablation, we used the double transgenic
MOGi-Cre/iDTR mice that express the diphtheria toxin receptor
specifically in oligodendrocytes. Previous studies have shown that
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results in loss of oligodendrocytes and demyelination after 230
days [28]. However, the effect on axonal and neuronal number
was not investigated in this study. To explore this issue, 10-week-
old MOGi-Cre/iDTR mice received 400 ng of DT via daily
intraperitoneal injections on seven consecutive days. Age- and sex-
matched MOGi-Cre/iDTR mice that received PBS injections and
MOGi-Cre mice (lacking the iDTR allele) that received DT
injections served as controls in these experiments. After 30 days,
when clinical symptoms such as tremor and unbalanced gait were
detected in the treated group, animals were sedated, perfused
transcardially, fixed and processed for immunohistochemistry. To
analyze the extent of demyelination in the corpus callosum caused
by oligodendrocyte ablation, coronal slices were stained with
Luxol fast blue–periodic acid Schiff (LFB-PAS) and demyelination
was evaluated according to a standardized score from 0 (no
demyelination) to 3 (complete demyelination). Consistent demy-
elination was observed in DT-treated MOGi-Cre/iDTR mice, but
was absent in the control animals. In line with this finding, a lower
number of oligodendrocytes were observed in DT-treated MOGi-
Cre/iDTR mice (Fig. 1). In addition, reactive astrogliosis and
activated microglia were detected in DT-treated MOGi-Cre/
iDTR mice (Fig. 2).
Next, sections were stained for neurofilament 200 (NF200) to
evaluate axonal structures. Images of the midsagittal line of the
corpus callosum from coronal sections were obtained under equal
acquisition parameters using a confocal microscope and the signal
intensity was analysed with Image J. We observed substantial
damage of axons in DT-treated MOGi-Cre/iDTR mice as
compared to the controls (Fig. 3). In damaged or transected
axons, transported molecules and organelles accumulate in the
axon and consequently increased amounts of amyloid precursor
protein (APP) are frequently detected [27,29]. We therefore
analyzed the axonal pathology in more detail, by performing
immunostainings for APP. These experiments revealed a substan-
tial accumulation of APP in the axons of DT-treated MOGi-Cre/
iDTR mice, but not in controls (Fig. 3). To determine whether
neuronal loss had occurred, we performed a computer-assisted
analysis of neuronal densities in defined cortical areas: Sections
immunostained with the neuronal marker NeuN were scanned
and neuronal densities were evaluated. We found that oligoden-
drocyte ablation did not result in any significant differences in
neuronal cell number (Fig. 3), nor densities. In addition, we could
not detect apoptotic neuronal cells by fluorescein-12-deoxy-UTP
nick-end labeling (TUNEL) staining (Fig. S1). Together, these
results indicate that acute depletion of oligodendrocytes induced
axonal injury, but does not cause detectable neuronal cell death 30
days post treatment.
Glial ablation triggers neuronal apoptosis in adult
Drosophila
Next, we used Drosophila melanogaster as a model system to
analyze the impact of glia ablation on neurons in an invertebrate
system. Approximately 10% of the cells of the adult Drosophila
melanogaster CNS are of glial origin. To ablate these cells, we used
the UAS/GAL4-system [30]. Glial-specific expression of UAS-
transgenes was mediated using the repo-GAL4 driver [31,32]. The
driver line repo-GAL4 is active already in early fly development. In
order to prevent GAL4 dependent expression of UAS-transgenes
in development, we made use of a temperature-sensitive allele of
the GAL4 repressor GAL80
ts [33]. At restrictive temperature
(18uC), GAL80 efficiently suppressed GAL4-dependent activation
of UAS-transgenes. Shifting adult flies to permissive temperature
(29uC), GAL80
ts looses its suppressor activity and GAL4 induces
the expression of genes under UAS control. To ablate glia, we
induced apoptosis specifically in glia by expressing the proapopto-
tic gene reaper in the adult fly using the repo-GAL4 driver in
combination with GAL80
ts.
We performed TUNEL staining and immunofluorescence
analyses using antibodies against neuronal and glial markers to
detect apoptotic cells and observed massive induction of neuronal
apoptosis after triggering cell death in glia (Fig. 4). Quantitative
analysis of brain sections examined 0, 3 and 10 days after
induction of glial apoptosis, revealed a significant increase in
number of TUNEL-positive neurons (Elav-positive cells). Apo-
ptotic neurons were almost absent from control brains. To
examine the consequences of glial cell death on the survival of the
flies, we performed longevity analysis. After the induction of glial
cell death, there was a striking reduction in the lifespan of adult
flies as compared to control flies. In addition, flies display negative
geotaxis, an easy measure of the ability to climb away from gravity.
These experiments revealed dramatic climbing deficits after glia
ablation (Fig. 5). Taken together, our results show that the
induction of apoptosis in glia of adult flies has a dramatic impact
on neuronal survival.
Discussion
We have shown that selective depletion of glia in the adult
vertebrate and invertebrate nervous system results in secondary
severe axonal damage or neuronal loss. Targeted genetic ablation
of glia was achieved in the adult Drosophila nervous system using
the UAS/GAL4 system in combination with the temperature
sensitive suppressor of GAL4, GAL80
ts. In mice, oligodendrocytes
were depleted by the injection of DT into MOGi-Cre/iDTR
double transgenic mice. In both experimental systems the acute
depletion of glia induced massive neurotoxicity. These findings are
of relevance for interpretation of neurodegeneration in diseases
with glial pathology. For example, in patients with MS the
neurodegeneration is thought to be the leading cause for
permanent disability, but the mechanisms that trigger neurode-
generation are still under debate [27,34]. Two major – but
mutually not excluding – scenarios could be envisaged. An
inflammatory response consisting of autoreactive CD8
+ T cells,
antibodies and complement or activated microglia/macrophages
may directly attack the axons [35]. Alternatively, axonal damage
might be secondary to demyelination. It has been difficult to
distinguish between these different possibilities in EAE. Recently, a
genetic model that enables the ablation of oligodendrocytes in the
mouse nervous system was described. By using an inducible Cre/
loxP recombination system, the A subunit of diphtheria toxin was
specifically expressed in oligodendrocytes [36]. Interestingly and in
contrast to our study, the oligodendrocyte ablation, and the
resulting demyelination, did not induce axonal loss in the optic
nerve or spinal cord. The reason for these different outcomes is
likely to be found in the nature of the different models. The
induction of the A subunit of diphtheria toxin in oligodendrocytes
by tamoxifen treatment of PLP/CreER
T; ROSA26-eGFP-DTA mice
may result in a less efficient and less extensive ablation as
compared to the approach used in our study. While our paper was
in revision, Pohl et al. [37] presented another model of
oligodendrocyte depletion using a tamoxifen (TAM)-dependent
PLPCreERT2 allele in combination with a Cre-dependent
diphtheria toxin fragment A (DT-A) transgene in the ubiquitously
expressed ROSA26 locus. In this study, in coherence with our
results, axonal damage was observed as detected by a reduction in
neurofilament staining intensity and an increase in APP accumu-
lation compared to control.
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attack has major influence on the response of the axons. It is
possible that the rapid or widespread death of oligodendrocytes
overwhelms the defence mechanisms of the brain. There are a
number of oligodendrocyte mouse mutants that result in axonal
degeneration, but some of them require several months to develop
Figure 1. Oligodendrocyte depletion with Diphtheria Toxin in MOGi-Cre/iDTR mice. MOGi-Cre/iDTR mice were injected with 400 ng
diphtheria toxin (DT) daily, for 7 days. After 30 days, the level of demyelination was assessed by LFB-PAS staining, and the number of mature
oligodendrocytes, by NogoA staining. A decrease of myelination and of mature oligodendrocyte number was observed in MOGi-Cre/iDTR mice
treated with DT (left panel), compared to DT-treated MOGi-Cre animals as control (middle panel) and MOGi-Cre/iDTR animals treated with PBS (right
panel). For quantification one-way ANOVA was performed, followed by pairwise Tukey test. Statistical significance is represented with asterisks (n=3–
9, **p,0.01, ***p,0.001). Scale bar, 100 mm.
doi:10.1371/journal.pone.0022735.g001
Glial Ablation Triggers Neurotoxicity
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22735robust degeneration. For example, mouse mutants that lack some
of the major myelin genes such as myelin-associated glycoprotein
(MAG), the 29,39- cyclic nucleotide 39- phoshodiesterase (CNP)
and the proteolipid protein (PLP) have an almost normal live span
and develop late-onset, chronic progressive axonal degeneration
[15,16,38]. Interestingly, the neuronal pathology in MS seems also
to be primarily directed against the axon, as axonal loss is more
frequently found than loss of neuronal cell bodies [27]. However,
Figure 2. Asrocytosis and microglia activation is observed after DT-induced demyelination in MOGi-Cre/iDTR mice. Coronal sections
from MOGi-Cre/iDTR mice treated with DT (left panel), DT-treated MOGi-Cre animals as control (middle panel) and MOGi-Cre/iDTR animals treated
with PBS (right panel) were stained for astrocytes (GFAP) and microglia/macrophages (Mac3) 30 days after injection. Quantification of astrocyte and
microglia/macrophage density in central corpus callosum is shown as mean 6 SEM (n=3–7). If ANOVA indicated significant differences in the main
effect (p,0.05), Tukey test pairwise comparison was applied. Statistically significant differences are indicated by asterisks (**p,0.01, ***p,0.001).
Scale bar: 50 mm.
doi:10.1371/journal.pone.0022735.g002
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advanced stages of the disease so called secondary progressive MS
[39].
In contrast, the acute depletion of glia in the adult Drosophila
nervous system triggered apoptosis in neurons, motor paralysis and
death within a few days. Even if glia account for only ,10% of the
cells in the adult Drosophila nervous system, it is likely that their
ablation compromise the physiological environment of the CNS to
an extent that can not be compensated by the neurons. However,
when comparing the results between the Drosophila and the mice
models, it is important to note that we used the pan-glial driver repo
in the flies, whereas only oligodendrocytes were ablated in the
mice. It is therefore possible that a more widespread ablation of
glia would also result in apoptosis and an acute loss of neurons in
mice as observed in Drosophila. Such changes in the physiological
milieu of the CNS induced by glial dysfunction might be relevant
for a number of neurological diseases. For example, models of
diverse human neurodegenerative diseases, including amyotrophic
lateral sclerosis (ALS), Huntington’s disease and multiple system
atrophy (MSA) provide evidence that there are non-cell-autono-
mous mechanisms in which neurodegeneration is strongly
influenced by dysfunctional glia [40,41,42,43,44].
Together these studies indicate that glial dysfunction can trigger
neurotoxicity in a number of different ways. Our study shows that
the acute ablation of glia has an immediate impact on neuronal or
axonal viability. The results provide evidence that loss of
oligodendrocytes is sufficient to induce acute axonal damage and
underscores the central contribution of glia to neurodegenerative
diseases. Many previous studies have related demyelination with
an axonal pathology that does not necessarily result in actual
axonal loss. In fact after transection in demyelinating diseases an
axon can degenerate while the neuronal cell body is able to survive
[27,45]. More research into the non-inflammatory mechanisms of
neurodegeneration will open new avenues for the treatment of
diseases such as MS. Importantly, the model used in this study
provides a valuable system for the investigation of therapeutic
strategies to prevent axonal or neuronal damage.
Materials and Methods
Mice and perfusions
Animal experiments were conducted in accordance with animal
protection laws approved by the Government of Lower Saxony,
Germany. 10-week-old MOGi-Cre/iDTR mice [46,47] were
injected intraperitoneally with 400 ng of diphtheria toxin (DT,
Merck) in PBS once a day for seven days. Age- and sex-matched
MOGi-Cre/iDTR mice injected with PBS, and MOGi-Cre mice
(lacking the iDTR allele) injected with DT were used as controls.
After 30 days, when clinical symptoms such as tremor and
unbalanced gait were detected in the treated group, animals were
sedated with a 14% chloral hydrate intraperitoneal injection,
perfused transcardially and fixed with 4% paraformaldehyde
(PFA). Tissue was processed as described previously [48,49]. After
paraffin embedding 3 mm thick sections of the brain, spinal cord,
spleen and liver were obtained.
Histological analysis
The extent of demyelination induced by DT injection was
assessed by scoring the animals from 0 (no demyelination) to 3
(complete demyelination) in sections stained with Luxol fast blue–
periodic acid Schiff (LFB–PAS) [50] by a double-blinded observer.
Immunohistochemistry was performed using antibodies against
neuronal nuclei (NeuN Chemicon, Temecula, CA, USA) and
against the amyloid precursor protein (APP, clone 22C11;
Chemicon, CA, USA) followed by labelling with biotinylated
secondary antibodies. Avidin-biotin technique with 3,3-diamino-
benzidine was used for visualization. Fluorescence immunohisto-
chemistry was performed for neurofilament 200 (NF200, clone
N52, Sigma) with Alexa488-conjugated chicken anti-mouse IgG
secondary antibodies (Invitrogen). To assess axonal preservation,
images of each side of the midsagittal line of the corpus callosum
from coronal sections stained with NF200 were obtained under
equal acquisition parameters with a confocal microscope (LSM
510, Carl Zeiss MicroImaging, Inc). At each side of the midsagittal
line, the NF200-positive area (which allows the demarcation of the
corpus callosum and its distinction from the ventricular and
cortical areas), was taken as ROI and analyzed with imageJ. The
signal density is given by the average gray value per square
micrometer of the ROI, which is independent of surface area.
Histological sections stained with anti-APP counterstained with
Haemalaun, and with NeuN antibody were scanned using the
Mirax Midi System (Carl Zeiss Micro Imaging GmbH).
Neuronal numbers semi-automated analysis
Sections stained for neuronal nuclei with NeuN antibodies were
scanned as described above. Neuronal numbers were automati-
cally counted using a script in Cognition Network Language based
upon the Definiens Cognition Network TechnologyH platform
(Definiens Developer XD software, Munich, Germany). Briefly,
the cortical region of interest was drawn manually and NeuN
positive cells were detected based on color criteria. After finer
segmentation to discriminate between nucleus and cytoplasm, the
object was classified as a NeuN-positive cell if the soma was below
a certain size and had 0 or 1 nucleus. If more than one nucleus was
detected within one soma, the object was split using each nucleus
as seed to grow into the surrounding cytoplasm, stopping if
growing borders converged or the cytoplasmic border was
reached. Finally, the total number and density of NeuN-positive
cells was calculated.
Drosophila stocks and genetics
The following fly stocks were used: w[1118];
P{w[+m*]=GAL4}repo/TM3 referred to as repo–GAL4 in text,
w[*]; P{w[+mC]=tubP-GAL80[ts]}, referred to as tub-GAL80
ts,
in text, w[1118]; P{w[+mC]=UAS-rpr.C}, referred to as UAS-
Figure 3. Oligodendrocyte depletion with DT results in axonal damage but does not affect cortical neuronal density. (A) A decrease
of neurofilament signal density (NF200), and an increase in axonal damage (evidenced by APP accumulation) was observed in MOGi-Cre/iDTR mice
treated with DT (left panel), compared to DT-treated MOGi-Cre animals as control (middle panel) and MOGi-Cre/iDTR animals treated with PBS (right
panel). Quantifications are shown as mean and SEM (n=3–10). One way ANOVA was performed, followed by pairwise Tukey test. Significance is
represented with asterisks (**p,0.01, ***p,0.001). Scale bar, 100 mm. (B) Coronal sections were stained for neuronal nuclei with NeuN antibodies,
scanned with Mirax Midi System and automatically counted using Definiens Developer XD software in the indicated region of interest (ROI). One way
ANOVA was performed, no statistically significant difference in neuronal density was observed between the groups. Also, no significant difference
was found in cortical volume between the groups (p.0.05). An average of 10104 NeuN+ were counted per animal. Quantifications represent mean
and SEM (n=8 MOGi-Cre/iDTR mice treated with DT, 5 DT-treated MOGi-Cre animals as control (middle panel) and 3 MOGi-Cre/iDTR animals treated
with PBS, ns: not significant).
doi:10.1371/journal.pone.0022735.g003
Glial Ablation Triggers Neurotoxicity
PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22735Glial Ablation Triggers Neurotoxicity
PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e22735reaper in text. OregonR served as wild-type control. All stocks
were obtained from the Bloomington Stock Center (Indiana
University, Bloomington, IN USA). Flies were maintained on
normal commensal-yeast-agar medium.
By combining glial specific driver repo-GAL4 [31] with
ubiquitously expressed temperature-sensitive allele of GAL80
ts
we generated a fly line (w; tub-GAL80
ts; repo-GAL4/TM3, Sb)
referred to as tub-GAL80
ts; repo-GAL4 [33], allowing expression
of reaper [51] specifically in adult glia. Crossings of UAS-reaper
with tub-GAL80
ts; repo-GAL4 flies were set at 18uC to minimize
the expression of reaper. At 18uC the ubiquitously expressed
GAL80
ts blocks repo-GAL4-dependent activation UAS-reaper.
Figure 4. Glial ablation in adult Drosophila results in neuronal apoptosis. (A) Glial cell death was induced in transgenic flies by expressing
Reaper for 10 days in adult flies (UAS–reaper/tub–GAL80
ts;repo–GAL4/+. Double-label immunofluorescence and TUNEL staining on brain sections.
Colocalization of the glial-specific protein repo and the neuronal-specific protein elav (red) with TUNEL-positive nuclei (green) reveals the presence of
apoptotic glial and neuronal nuclei (arrows). (B) Double-label immunofluorescence and TUNEL on brain of control flies (genotype: tub–GAL80
ts/+;
repo–GAL4/+). Scale bar, 20 mm. (C) Quantitative analysis of TUNEL-positive neurons. Statistical analysis was performed with an unpaired t test
(***p,0.001, Error bar is 6 SEM).
doi:10.1371/journal.pone.0022735.g004
Figure 5. Glial ablation in adult Drosophila reduces lifespan and impairs locomotion. (A) Glial cell death was induced in transgenic flies by
expressing reaper for 10 days in adult flies (UAS–reaper/tub–GAL80
ts;repo–GAL4/+). UAS-reaper and tub–GAL80
ts/+;repo–GAL4/+ were used as negative
control. (B) Median survival of respective survival curve. (C) Summary of statistical significance (Log-rank-Mantel-Cox Test) by cross-comparing the
survival curves. (D) Locomotion defect of flies was analyzed with negative geotaxis and was quantified 10 days after shifting the flies from 18uCt o
29uC in a countercurrent apparatus. Experimental flies (UAS–reaper/tub–GAL80
ts; repo–GAL4/+) were compared to control flies (tub–GAL80
ts/+; repo–
GAL4/+) in group1 and group3 to have better assessment of motor defect. One-way ANOVA followed by Bonferroni post hoc test was used for
statistical significance (*p,0.05, **p,0.001, ***p,0.0001, ns not significant).
doi:10.1371/journal.pone.0022735.g005
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genotypes UAS-reaper/tub-GAL80
ts;repo-GAL4/+ and tub-
GAL80
ts/+;repo-GAL4/+ (control) were switched to 29uCt o
inactivate the temperature-sensitive GAL80, thereby allowing the
expression reaper in glia. We used this system to ablate adult glia in
Drosophila.
Longevity assay
To deplete the mature glial cells tub-GAL80
ts; repo-GAL4 flies
were crossed with UAS-reaper, and OregonR (negative control).
3–4 days post-hatching adult males with the respective combina-
tion of GAL4-driver, UAS-transgene and GAL80
ts were shifted to
29uC (10–15 flies per vial). Numbers of dead flies were counted
daily. Fresh fly food was provided every 2–3 days. At least 50 flies
per genotype were used for the assay. Log Rank Test (Mantel-Cox)
was used to test for statistical significance.
Climbing Assay
30–40 male flies per genotype were shifted to 29uC (3–4 days
post-hatching). 10 days after shifting to 29uC negative geotaxis
assay was performed to asses locomotion. In this assay, flies were
partitioned up into six tubes by giving them the choice five times to
stay or to climb up the side of the tube. After the assay, flies were
distributed into six tubes depending on how many times (between
0 and 5 times) they climbed up. To represent the distribution of
the flies, the number of the flies in the 1st and 2nd (group 1), 3rd
and 4th (group 2), and 5th and 6th (group 3) tubes were summed
up and displayed in a bar graph [51].
TUNEL Assay
To detect apoptotic cells, in situ cell death detection kit from
Roche was used and performed according to manufacturer
protocol. To stop the terminal deoxynucleotidyl transferase-
mediated biotinylated UTP nick end labelling (TUNEL) reaction
saline-sodium citrate buffer (Promega) was used.
Immunohistochemistry
Adult Drosophila brains were dissected in 16PBS +0.1% Triton
X-100 (PBT) and fixed with 4% PFA for 30 min at room
temperature. Primary antibodies (both obtained from Develop-
mental Studies Hybridoma Bank) anti-Repo (1:100) and anti-Elav
(1:200) were diluted in PBT with 2% horse serum and incubated at
4uC overnight. For primary antibody detection, Cy3-coupled
antibodies anti mouse or rat (Dianova) were used in a 1:200
dilution, respectively. After extensive washing, brains were
mounted with Vectashield (Vectorlab)+ DAPI and images were
taken with a confocal microscope (Leica LSM/SP2). Central brain
region was imaged and analyzed for quantification. Image
processing was performed with ImageJ.
Statistical analysis
For the histological analysis of the diphtheria toxin assay, a one-
way ANOVA was performed, followed by a Tukey test for
pairwise comparisons, if applicable. For Drosophila glia ablation,
unpaired t-test was performed for the histological analysis of
TUNEL-positive neurons, as well as a Log-rank-Mantel-Cox Test
for the cross-comparison of survival curves and one-way ANOVA
followed by Bonferroni post hoc test for motor defect time course
analysis. A p-level of ,0.05 was considered significant in all tests.
Statistics were calculated using GraphPad prism and SigmaPlot
software (Systat software, Inc.).
Ethics Statement
All animal treatments were approved in advance by the Lower
Saxony state authorities (‘‘Niedersa ¨chsisches Landesamt fu ¨r
Verbraucherschutz und Lebensmittelsicherheit’’; Postfach 39 49;
26029 Oldenburg) for animal experimentation and conducted in
accordance with animal protection laws approved by the
Government of Lower Saxony, Germany. The Approval ID is:
33.14-42502-04-068/09) and the project name ‘‘Mechanismen der
chronischen Progredienz bei Multipler Sklerose’’).
Supporting Information
Figure S1 Coronal sections of cortex from MOGi-Cre/
iDTR mice treated with DT (left panel), DT-treated
MOGi-Cre animals as control (middle panel) and MOGi-
Cre/iDTR animals treated with PBS (right panel) were
stained for TUNEL and NeuN 30 days after injection.
Sections of the spleen of the respective groups were used as
positive control for the TUNEL stainings. Colocalisation of DAPI
and TUNEL-positive cells is shown as an inset for each group.
Scale bar: 50 mm, for inset 10 mm.
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